首頁
Nona Biosciences

3月 2026Nona Biosciences的市場佔有率分析

Discover Nona Biosciences' pioneering fully human heavy chain only antibodies (HCAb/VHH) Harbour Mice® platform, driving innovation in next-gen therapeutic modalities. Explore how our advanced single-domain antibody technology accelerates the development of bispecifics, ADCs, CAR-T therapies, and more.

行業: N/A

域名nonabio.com

成立年份2022

僱員51 - 200

年度營收--

Nona Biosciences

Nona Biosciences（包含公司地區）

nonabio.com

查看更多網站流量與參與度資訊

Nona Biosciences的熱門網域總造訪量

了解Nona Biosciences市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

nonabio.com10K

透過銷售情報查看更多內容

Nona Biosciences的熱門網域平均造訪時長

分析Nona Biosciences參與度指標。

過去 3 個月平均造訪時長

子公司細目

nonabio.com00:00:02

透過銷售情報查看更多內容

Nona Biosciences的熱門網域平均頁面瀏覽量

了解Nona Biosciences如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

nonabio.com1.34

透過銷售情報查看更多內容

Nona Biosciences按網域劃分的熱門競爭對手

3月 2026的熱門類似網站，依相似度排名

harbourbiomed.com公司名Harbour BioMed僱員51 - 200總部美國, 馬薩諸塞州, Cambridge年度營收$25M - $50M訪問總量6.3K健康 > 生物技術和製藥

使用的熱門技術Nona Biosciences

这些是Nona Biosciences顶级域名使用的行业网站技术

付費廣告 (5)

DoubleClick

小工具 (5)

Twemoji

行動裝置 (3)

Meta Viewport

轉換與分析 (2)

Google Analytics

更多技術

9

檢視所有

新聞與訊號來自Nona Biosciences

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Nonabio partnered with Link Cell Therapies, Inc on Jan 9th '26.Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology platforms, today announced that it has entered into a multi-target antibody discovery collaboration with Link Cell Therapies.

新聞Valinktx partnered with Nonabio on Dec 17th '25.December 17, 2025 - Cambridge, USA and London, UK - Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and Nona Biosciences ("Nona"), a global biotechnology company providing integrated solutions for biological drug discovery and development from "Idea to IND" (I to I(R), today announced the formation of a strategic biologics discovery alliance.

新聞Nonabio hired Hongjiang Miao as Chief AI Officer on Dec 4th '25.CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ - Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I(R)(Idea to IND), today announced the appointment of Dr. Hongjiang Miao as Chief AI Officer.